Funded Grants

Moving neuroscience research from the lab and turning it into a product is extremely challenging. Even the most groundbreaking technologies may never improve a patient’s life if the commercialization path is not successfully navigated.

Stroke is a leading cause of adult and childhood focal brain injury and disability.

Decades of dance research have demonstrated the positive benefits of dance in terms of improving quality of life and reducing symptomatology for diverse groups of participants.

Stroke is a life threatening emergency caused by blocked arteries that affects 45,000 Canadians a year. Each hour a stroke is left untreated means brain cells are dying.

The overall goals of the Canadian Partnership for Stroke Recovery Clinical Trials Platform is to create a national network of stroke rehabilitation clinical trial sites, help train future researchers and test potential high impact new recovery approaches.

Parkinson’s Disease (PD) is a debilitating neurodegenerative disease for which there is no cure.

As our brains age, they become vulnerable to diseases such as Alzheimer’s disease which can cause dementia.

Magnetic Seizure Therapy (MST) is a novel form of treatment that uses high intensity magnetic field pulses to stimulate the brain and induce a seizure as a therapeutic intervention for patients with depression resistant to antidepressant medication, known as Treatment Resistant Depression (TRD).

Synaptic plasticity is the process where the strength of connections between nerve cells is altered by experience.

New approaches in neurodevelopmental research increasingly seek to integrate enormous amounts of data through sophisticated informatics so as to determine the relationship between genotype and phenotypes, both structural and functional, as they change over time during development.